PTK2 and neoplasm: FAK inhibition was shown to reduce tumor cell contractility and membrane tension, along with ECM stiffness, thereby enhancing CRISPR gene editing efficiency in tumor cells both in vitro and in vivo by promoting lipid nanoparticles (LNPs) endocytosis and tumor penetration.